ESSA Pharma Inc. (EPIX) has disclosed a new risk, in the Debt & Financing category.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
ESSA Pharma Inc.’s management holds significant discretion over the allocation of its cash reserves, which poses a potential risk to the company’s operational outcomes. The decisions made regarding these cash resources may not align with shareholder expectations or contribute to enhancing shareholder value. Ineffective utilization of these funds could materially impact ESSA’s business, hinder the progress of product development, and precipitate a decline in the market value of its Common Shares. Furthermore, interim investments of unused cash might not yield substantial income or could potentially depreciate, exacerbating financial challenges.
Overall, Wall Street has a Hold consensus rating on EPIX stock based on 5 Holds.
To learn more about ESSA Pharma Inc.’s risk factors, click here.
